Management of Treatment-Experienced HIV-Infected Patients

  • Author: Eric S. Daar, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/1/18 (What's New)

Summary

  • Drug selection must rely on understanding drug–drug and drug–food interactions, convenience, tolerability, clinician’s experience, and goal of preserving treatment options
  • Resistance test of limited use in patients off treatment for some time; clinicians must decide if 2 or 3 fully active drugs can be reliably identified
    • In absence of medical records, may be ideal to use drugs in newer classes (and not previously received by patient) in combination with NRTIs, an NNRTI, and/or a ritonavir-boosted PI

Action required